Nathan Singh

3.6k citations
36 papers · 2.0k · 1 hit paper · h-index 19

Impact in

  • Oncology top 2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 29
    • Immune Cell Function and Interaction 8
    • T-cell and B-cell Immunology 3

Nathan Singh

35 papers receiving 1.9k citations

Nathan Singh's Hit Papers

Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering 2020 · 488 citations
4880+2+4Years since publication100200300400

Peers

Nathan Singh
Comparison fields: 5 of 89
  • Oncology 1.2k
  • Immunology 553
  • Genetics 375
  • Molecular Biology 735
  • Biomedical Engineering 452
Replace Frédéric Lézot with:
Frédéric Lézot France
Zeyu Chen China
Marc Baud’huin France
Jérôme Amiaud France
Jacson Shen United States
Steve Stegen Belgium
Xianghua Wu China
Ivy Tran United States
Niwa Ali United Kingdom
Jingjing Li China
Nathan Singh relative to Frédéric Lézot France Frédéric Lézot's profile →
Citations per field
00.5×3.3×
Frédéric Lézot · 1×
Citations per year

Countries citing papers authored by Nathan Singh

Since Specialization
Citations

This map shows the geographic impact of Nathan Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Singh more than expected).

Fields of papers citing papers by Nathan Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Singh. The network helps show where Nathan Singh may publish in the future.

Co-authors

The 25 scholars most cited alongside Nathan Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nathan Singh Line = papers co-authored together Nathan Singh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Hit paper breakdown →
2020488
2 2013273
3 2016232
4 2017117
5 2014109
6 2010105
7 201477
8 200672
9 201467
10 201764
11 201657
12 202244
13 201532
14 201531
15 201929
16 202327
17 200925
18 201622
19 201719
20 201713

About Nathan Singh

Nathan Singh is a scholar working on Oncology, Immunology, Genetics, Molecular Biology and Biomedical Engineering, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (29 papers), Virus-based gene therapy research (9 papers), Immune Cell Function and Interaction (8 papers), Nanowire Synthesis and Applications (7 papers), CRISPR and Genetic Engineering (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (553 citations), Genetics (375 citations), Molecular Biology (735 citations) and Biomedical Engineering (452 citations). Nathan Singh has collaborated with scholars based in United States, Germany and Philippines. Frequent co-authors include Carl H. June, Stephan A. Grupp, David M. Barrett, Margaret M. Billingsley, Rui Zhang, Pranali Ravikumar, Michael J. Mitchell, David M. Barrett, Jessica Perazzelli and David L. Porter. Their work appears in journals such as Blood, Cancer Immunology Research, Journal of Clinical Oncology, Cytotherapy and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact